Matsukura S, Kakita T, Sueoka S, Yoshimi H, Hirata Y, Yokota M, Fujita T
Cancer Res. 1980 Oct;40(10):3768-71.
Adenylate cyclase responses to pituitary hormones including adrenocorticotropic hormone (ACTH), biogenetic amines, prostaglandin E1 (PGE1), angiotensin II, and glucagon were evaluated in adrenocortical tumors and hyperplastic adrenal tissues, obtained from patients with Cushing's syndrome at surgery, and in normal adrenals. The adenylate cyclase of two normal adrenals was activated only by ACTH and PGE1 among the hormones tested, while that of two hyperplastic adrenal tissues due to excessive pituitary ACTH secretion was stimulated only by ACTH. Of five ACTH-responsive adrenocortical adenomas, in contrast, three were stimulated by norepinephrine, two by epinephrine, one by thyroid-stimulating hormone, and one by luteinizing hormone in addition to ACTH, indicating the presence of multiple receptors for hormones other than ACTH and PGE1 in these four tumors. The cyclase of an ACTH-unresponsive adrenocortical carcinoma ws activated only by PGE1 and not by other hormones including ACTH, whereas that of an ACTH-responsive adrenocortical nodular hyperplasia was stimulated by ACTH and glucagon but not by other hormones including PGE1. These results indicate the presence of multiple receptors for hormones other than ACTH and PGE1, the normal adrenocortical stimulants, in human adrenocortical tumors, particularly in adrenal adenomas, but not in normal and hyperplastic (of whichever an etiology) adrenocortical tissues, suggesting a functional alteration of the cellular membrane receptors in human adrenocortical tumors.
对取自库欣综合征患者手术切除的肾上腺皮质肿瘤和增生性肾上腺组织以及正常肾上腺,评估了腺苷酸环化酶对包括促肾上腺皮质激素(ACTH)、生物胺、前列腺素E1(PGE1)、血管紧张素II和胰高血糖素在内的垂体激素的反应。在所测试的激素中,两个正常肾上腺的腺苷酸环化酶仅被ACTH和PGE1激活,而由于垂体ACTH分泌过多导致的两个增生性肾上腺组织的腺苷酸环化酶仅被ACTH刺激。相比之下,在五个对ACTH有反应的肾上腺皮质腺瘤中,除ACTH外,三个被去甲肾上腺素刺激,两个被肾上腺素刺激,一个被促甲状腺激素刺激,一个被促黄体生成素刺激,表明这四个肿瘤中存在除ACTH和PGE1之外的多种激素受体。一个对ACTH无反应的肾上腺皮质癌的环化酶仅被PGE1激活,而不被包括ACTH在内的其他激素激活,而一个对ACTH有反应的肾上腺皮质结节性增生的环化酶被ACTH和胰高血糖素刺激,但不被包括PGE1在内的其他激素刺激。这些结果表明,在人类肾上腺皮质肿瘤,特别是肾上腺腺瘤中,存在除正常肾上腺皮质刺激物ACTH和PGE1之外的多种激素受体,但在正常和增生性(无论病因如何)肾上腺皮质组织中不存在,这表明人类肾上腺皮质肿瘤中细胞膜受体存在功能改变。